Biology and pathobiology of apoE in aging and Alzheimer's disease
Biology and pathobiology of apoE in aging and Alzheimer's disease
批准号:
10407934
负责人:
ALISON M GOATE
金额:
$657.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-05-31
关键词:
AddressAgeAge-associated memory impairmentAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAlzheimer&aposs disease therapyAmyloid beta-ProteinAnimalsApolipoprotein EAstrocytesAutomobile DrivingAutopsyBiochemicalBiochemistryBioinformaticsBiological MarkersBiological ModelsBiologyBiometryBiophysicsBlood VesselsBrainCell NucleusCellsCollaborationsCollectionCommunitiesDataData SetDevelopmentDiseaseDisease PathwayEnsureEventFosteringGenesGeneticGenomicsGenotypeGoalsHumanImpaired cognitionInformation ResourcesInstitutionInterruptionKnowledgeLightLinkLipid BindingLipidsLipoproteinsLiquid substanceMediatingMicrodialysisMicrogliaModelingMolecularMusNeurosciencesOrganoidsOutcomePathogenicityPathologicPathologyPathway interactionsPatientsPhysiologicalPost-Translational Protein ProcessingPrevention strategyPropertyProtein IsoformsProteinsProteomicsReagentRecommendationResearchResearch PersonnelResource SharingResourcesRiskRisk FactorsStructureSystemTestingTherapeuticTimeUnited States National Institutes of HealthVascular Cognitive ImpairmentWorkage relatedaging brainbasebiomarker discoverybiophysical propertiesbrain cellcell typedata managementdesignfunctional outcomesgenetic analysisgenetic risk factorhealthy agingimprovedin vivoinduced pluripotent stem cellinnovationinsightlarge datasetslipid metabolismlipidomicsmetabolomicsmouse modelmultidisciplinarymultiple omicsneuropathologyparticlepreventprotective allelerisk variantsingle-cell RNA sequencingstructural biologysymposiumsynergismtargeted treatmenttau Proteinstherapeutic developmenttreatment strategyweb portal
中文摘要
项目概要(载脂蛋白E U19:总体)
这个U19项目的首要目标是全面了解的生物学和病理生物学,
载脂蛋白E(apoE)在衰老和阿尔茨海默病(AD)中的作用,为治疗策略提供信息。ε4等位基因
APOE基因(APOE 4)是AD最强的遗传风险因素,影响50-70%的AD患者,
与常见的ε3等位基因相比,ε2等位基因具有保护性。APOE 4也是年龄相关性高脂血症的一个强风险因素。
认知能力下降和血管性认知障碍。为了整合现有知识并弥补关键差距,
我们提出了一个统一的ApoE级联假说,即结构差异和相关的生化
三种apoE亚型之间的特性启动了它们对细胞内级联事件的差异效应,
和系统水平,最终影响衰老相关的致病性疾病,包括AD。为此,我们
组建了一个多学科团队,以协同多个机构的专业知识和资源。通过
整合五个互动项目和七个强大的核心,我们将为apoE相关衰老建立一个联系
研究,与更广泛的科学界分享知识,专业知识和资源。项目1将
与核心B密切合作,研究三种apoE亚型的结构和生化特性,
为功能性成果提供见解。项目2、3和4将交互式研究apoE亚型
在星形胶质细胞、小胶质细胞或血管壁细胞中表达影响脂质代谢、神经胶质和血管功能,
AD相关的病理学,以及使用条件性小鼠模型和系统的细胞和分子途径-
基于方法。这些研究将产生细胞类型特异性apoE/脂蛋白颗粒,
通过体内微透析收集用于结构和生化研究。项目5将进行基因组
和遗传分析,以确定AD发病时APOE相关年龄的修饰剂。项目2-5的研究将
交互式补充神经病理学研究,使用健康老龄化研究的死后大脑
或AD病理学(核心C),使用人和小鼠生物标本的生物标志物研究(核心D),以及
使用人iPSC衍生的细胞和类器官模型的功能研究(核心E)。U19提案是
由全面的多组学核心(核心F)支持,用于集中的蛋白质组学,脂质组学,
对各种动物和iPSC模型以及人类死后大脑和体液的代谢组学研究
生物标本生物信息学、生物统计学和数据管理核心(核心G)将提供关键的
支持分析大型数据集,包括来自单细胞RNA-seq和生物统计学的数据集,
确保科学严谨。核心G还将与行政核心(核心A)密切合作,
指定为EPAAD的门户网站,将与科学家共享知识,资源和数据。
社区核心A还将组织年度ApoE研讨会,以促进合作并吸引ApoE
社区因此,U19将推动以团队为基础的努力,以产生指导疾病的基本知识-
改变AD和其他衰老相关疾病的治疗方法。
英文摘要
PROJECT SUMMARY (APOE U19: OVERALL)
The overarching goal of this U19 project is to comprehensively understand the biology and pathobiology of
apolipoprotein E (apoE) in aging and Alzheimer’s disease (AD) to inform therapeutic strategies. The ε4 allele of
the APOE gene (APOE4) is the strongest genetic risk factor for AD impacting 50-70% of all AD patients, while
the ε2 allele is protective compared to the common ε3 allele. APOE4 is also a strong risk factor for age-related
cognitive decline and vascular cognitive impairment. To integrate existing knowledge and address critical gaps,
we propose a unified ApoE Cascade Hypothesis that the structural differences and related biochemical
properties among the three apoE isoforms initiate their differential effects on a cascade of events at the cellular
and systems levels ultimately impacting aging-related pathogenic conditions including AD. Towards this, we
have assembled a multi-disciplinary team to synergize expertise and resources across multiple institutions. By
integrating five interactive Projects and seven robust Cores, we will create a nexus for apoE-related aging
research, sharing the knowledge, expertise and resources with the broader scientific community. Project 1 will
work closely with Core B to address the structural and biochemical properties of the three apoE isoforms to
generate insights for functional outcomes. Projects 2, 3 and 4 will interactively study how apoE isoforms
expressed in astrocytes, microglia, or vascular mural cells impact lipid metabolism, glial and vascular functions,
AD-related pathologies, and cellular and molecular pathways using conditional mouse models and systems-
based approaches. These studies will generate cell type-specific apoE/lipoprotein particles that will be
collected through in vivo microdialysis for structural and biochemical studies. Project 5 will carry out genomic
and genetic analyses to identify modifiers of APOE-related age at onset of AD. Studies in Projects 2-5 will be
interactively supplemented by neuropathological studies using postmortem brains from healthy aging studies
or with AD pathologies (Core C), biomarker studies using both human and mouse biospecimens (Core D), and
functional studies using human iPSC-derived cellular and organoid models (Core E). This U19 proposal is
supported by a comprehensive Multi-Omics Core (Core F) for centralized proteomics, lipidomics, and
metabolomics studies on various animal and iPSC models, as well as human postmortem brains and fluid
biospecimens. The Bioinformatics, Biostatistics, and Data Management Core (Core G) will provide critical
supports for analyzing large datasets including those from single-cell RNA-seq and biostatistics supports to
ensure scientific rigor. Core G will also work closely with the Administrative Core (Core A) to maintain an ApoE
Web Portal designated as EPAAD where knowledge, resources, and data will be shared with the scientific
community. Core A will also organize annual ApoE Symposium to promote collaboration and engage the ApoE
Community. As such, this U19 will drive a team-based effort to generate essential knowledge to guide disease-
modifying therapies for AD and other aging-related conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
-
批准号:10552538
-
项目类别:
-
资助金额:$119.92万
-
财政年份:2022
-
负责人:ALISON M GOATE
-
依托单位:
2022 Neurobiology of Brain Disorders GRC and GRS
-
批准号:10468475
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2022
-
负责人:ALISON M GOATE
-
依托单位:
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
-
批准号:10301271
-
项目类别:
-
资助金额:$122.41万
-
财政年份:2022
-
负责人:ALISON M GOATE
-
依托单位:
Genetic modifiers of APOE-related risk for AD
-
批准号:10667481
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes
-
批准号:10295517
-
项目类别:
-
资助金额:$77.65万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Core A: Administrative
-
批准号:10295513
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Biology and pathobiology of apoE in aging and Alzheimer's disease
-
批准号:10667435
-
项目类别:
-
资助金额:$652.39万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Genetic modifiers of APOE-related risk for AD
-
批准号:10407948
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
-
批准号:10159826
-
项目类别:
-
资助金额:$159.55万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
-
批准号:10435506
-
项目类别:
-
资助金额:$158.77万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
-
批准号:10642872
-
项目类别:
-
资助金额:$158.47万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Genetics and Genomics Core
-
批准号:10406874
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer’s disease risk
-
批准号:9922452
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
-
批准号:10228580
-
项目类别:
-
资助金额:$85.29万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
-
批准号:10468712
-
项目类别:
-
资助金额:$83.55万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer’s disease risk
-
批准号:9751702
-
项目类别:
-
资助金额:$84.49万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Understanding the mechanism of SPl1 dependent Alzheimer disease risk
-
批准号:9194167
-
项目类别:
-
资助金额:$422.38万
-
财政年份:2016
-
负责人:ALISON M GOATE
-
依托单位:
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
-
批准号:8311728
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2010
-
负责人:ALISON M GOATE
-
依托单位:
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
-
批准号:8136599
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2010
-
负责人:ALISON M GOATE
-
依托单位:
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
-
批准号:8717549
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2010
-
负责人:ALISON M GOATE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: